Pharma's Almanac TV
PA TV
Follow the Journey
Become a Sponsor
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
Rooster Bio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Press Releases
2627 Articles Available
1
110
Can't find what you're looking for? Try our
advanced search
.
Genentech’s Phase III EMPACTA Study Showed Actemra Reduced the Likelihood of Needing Mechanical Ventilation in Hospitalized Patients With COVID-19 Associated Pneumonia
Migraines
REYVOW Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase Study
PR-M09-20-22
Immunotherapy
Novigenix Presents New Immuno-Transcriptomic Data for Prediction of Response to Immunotherapy in Metastatic Urothelial Cancer Patients
PR-M09-20-21
Leadership
Seqens CDMO North America Appoints Jean-Noel David as Managing Director
PR-M09-20-21
Ensiemo
SGD Pharma Introduces Ensiemo, the New Complete Child-Resistant Packaging Solution for CBD Oils
PR-M09-20-20
Data
Paradigm4 Launches Reveal Single Cell App for Analyzing Large Scale Data Sets
PR-M09-20-19
M&A
Gilead Sciences to Acquire Immunomedics
PR-M09-20-NI-18
Cell Therapy Capacity
Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs
PR-M09-20-NI-17
COVID-19
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India
PR-M09-20-NI-17
Oral COVID-19 Vaccine
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine
PR-M09-20-NI-19
Vaccine
Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating Pneumococcal Conjugate Vaccine
COVID-19 Vaccine
Pfizer and BioNTech Announce Data from Preclinical Studies of COVID-19 Vaccine Candidate
PR-M09-20-NI-15
Expansion
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion
PR-M09-20-NI-14
Diagnostic
LabCorp Launches First Combined Test for COVID-19, Flu and RSV in Time for Flu Season
PR-M09-20-NI-13
IPO
GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering
PR-M09-20-NI-13
IBM Watson Health and OrbitalRX to Launch Integrated Solution to Assist Hospital Pharmacy Providers in Managing Drug Shortages
PR-M09-20-NI-12
AstraZeneca, Oxford SARS-CoV-2 Vaccine Trials Temporarily Paused
PR-M09-20-NI-11
COVID-19 Vaccine Supply
CSL to Manufacture and Supply University of Queensland and Oxford University Vaccine Candidates for Australia
PR-M09-20-NI-10
COVID-19
Biopharma Leaders Unite to Stand with Science
PR-M09-20-NI-11
COVID-19 Vaccine
AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine
PR-M09-20-NI-08
Release
AES Releases 3 New Standard Cleanroom Models
PR-M09-20-NI-07
Partnership
AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
PR-M09-20-NI-06
COVID-19
CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research for Further COVID-19 Vaccine Development
PR-M09-20-NI-05
FDA Approval
FDA Approves First-of-its-Kind Automated Insulin Delivery and Monitoring System for Use in Young Pediatric Patients
PR-M09-20-NI-04
1
110
»
